RT Journal Article
SR Electronic
T1 Elucidating the clinical and molecular spectrum of <em>SMARCC2</em>-associated NDD in a cohort of 65 affected individuals
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.03.30.23287962
DO 10.1101/2023.03.30.23287962
A1 Bosch, Elisabeth
A1 Popp, Bernt
A1 Güse, Esther
A1 Skinner, Cindy
A1 van der Sluijs, Pleuntje J.
A1 Maystadt, Isabelle
A1 Pinto, Anna Maria
A1 Renieri, Alessandra
A1 Bruno, Lucia Pia
A1 Granata, Stefania
A1 Marcelis, Carlo
A1 Baysal, Özlem
A1 Hartwich, Dewi
A1 Holthöfer, Laura
A1 Isidor, Bertrand
A1 Cogne, Benjamin
A1 Wieczorek, Dagmar
A1 Capra, Valeria
A1 Scala, Marcello
A1 De Marco, Patrizia
A1 Ognibene, Marzia
A1 Jamra, Rami Abou
A1 Platzer, Konrad
A1 Carter, Lauren B.
A1 Kuismin, Outi
A1 van Haeringen, Arie
A1 Maroofian, Reza
A1 Valenzuela, Irene
A1 Cuscò, Ivon
A1 Martinez-Agosto, Julian A.
A1 Rabani, Ahna M.
A1 Mefford, Heather C.
A1 Pereira, Elaine M.
A1 Close, Charlotte
A1 Anyane-Yeboa, Kwame
A1 Wagner, Mallory
A1 Hannibal, Mark C.
A1 Zacher, Pia
A1 Thiffault, Isabelle
A1 Beunders, Gea
A1 Umair, Muhammad
A1 Bhola, Priya T.
A1 McGinnis, Erin
A1 Millichap, John
A1 van de Kamp, Jiddeke M
A1 Prijoles, Eloise J.
A1 Dobson, Amy
A1 Shillington, Amelle
A1 Graham, Brett H.
A1 Garcia, Evan-Jacob
A1 Galindo, Maureen Kelly
A1 Ropers, Fabienne G.
A1 Nibbeling, Esther AR
A1 Hubbard, Gail
A1 Karimov, Catherine
A1 Goj, Guido
A1 Bend, Renee
A1 Rath, Julie
A1 Morrow, Michelle M
A1 Millan, Francisca
A1 Salpietro, Vincenzo
A1 Torella, Annalaura
A1 Nigro, Vincenzo
A1 Kurki, Mitja
A1 Stevenson, Roger E
A1 Santen, Gijs W.E.
A1 Zweier, Markus
A1 Campeau, Philippe M.
A1 Severino, Mariasavina
A1 Reis, André
A1 Accogli, Andrea
A1 Vasileiou, Georgia
YR 2023
UL http://medrxiv.org/content/early/2023/04/03/2023.03.30.23287962.abstract
AB PURPOSE Coffin-Siris and Nicolaides-Baraitser syndromes, are recognisable neurodevelopmental disorders caused by germline variants in BAF complex subunits. The SMARCC2 BAFopathy was recently reported. Herein, we present clinical and molecular data on a large cohort.METHODS Clinical symptoms for 41 novel and 24 previously published cases were analyzed using the Human Phenotype Ontology. For genotype-phenotype correlation, molecular data were standardized and grouped into non-truncating and likely gene-disrupting variants (LGD). Missense variant protein expression and BAF subunit interactions were examined using 3D protein modeling, co-immunoprecipitation, and proximity-ligation assays.RESULTS Neurodevelopmental delay with intellectual disability, muscular hypotonia and behavioral disorders were the major manifestations. Clinical hallmarks of BAFopathies were rare. Clinical presentation differed significantly, with LGD variants being predominantly inherited and associated with mildly reduced or normal cognitive development, while non-truncating variants were mostly de novo and presented with severe developmental delay. These distinct manifestations and non-truncating variant clustering in functional domains suggest different pathomechanisms. In vitro testing showed decreased protein expression for N-terminal missense variants similar to LGD.CONCLUSION This study improved SMARCC2 variant classification and identified discernible SMARCC2-associated phenotypes for LGD and non-truncating variants, which were distinct from other BAFopathies. The pathomechanism of most non-truncating variants has yet to be investigated.Competing Interest StatementR.B. and J.R. are employees of PreventionGenetics, part of Exact Sciences. MM.M. and F.M. are employees of GeneDx, LLC. The other authors declare no competing interests.Funding StatementB.P. is supported by the Deutsche Forschungsgemeinschaft (DFG) through grant PO2366/2-1. A.R. received support from the German Federal Ministry of Research and Education (01GM1520A) as part of the Chromatin-Net Consortium.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Legal guardians gave written informed consent for genetic and clinical data, including photos and brain images, to be published. This study follows the Declaration of Helsinki protocols and is approved by the ethics committees of the Friedrich-Alexander-Universitaet Erlangen-Nuernberg, Germany (259_16 Bc), University of Leipzig Germany (224/16-ek and 402/16-ek), Leiden University Medical Center, Leiden, The Netherlands (G21.129), Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy (number of protocol 81/21), North Ostrobothnias Hospital District (19.4.2021, Eettmk 110), Greenwood Genetic Center, Self Regional Healthcare (IRB Number: Pro00085001), UMT - University of Management and Technology, Lahore, Pakistan {IRB Ref. Number: DLSBBC-2022-04}, Hospital vall dHebron (code C.0002416) and the Childrens Mercy Institutional Review Board (IRB) (Study # 11120514).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data supporting this article are provided in the supplementary files available in the online version of this article at the publisher's website or in the online repository Zenodo (Files S2, S3, S4: DOI: 10.5281/zenodo.7766791). https://zenodo.org/record/7766791#.ZCWs-nZBwQ9